BioCentury | Jul 2, 2020
Finance

SK becomes Korea’s third-largest public healthcare company after $800M IPO

...SCM Lifescience (KOSDAQ:298060) raised $154.3 million on June 17. Elizabeth S. Eaton, Staff Writer SK Biopharmaceuticals Co. Ltd. Gencurix Inc. SCM Lifescience...
BioCentury | Jun 3, 2020
Finance

Daily Chart: IPO queue grows to 20 life sciences companies

...Therapeutics Inc. Generation Bio Co. Avidity Biosciences LLC Vaxcyte Inc. Royalty Pharma Burning Rock Biotech Arya Sciences Acquisition Corp. SK Biopharmaceuticals Co. Ltd. SCM Lifescience Aptamer...
BioCentury | Apr 19, 2019
Company News

Allele, SCM partner to develop iPS cell therapies for diabetes

...companies will first focus on an autologous therapy for certain forms of Type IIIc diabetes. SCM Lifescience...
...acute pancreatitis, severe atopic dermatitis and liver cirrhosis. Elizabeth S. Eaton, Staff Writer Allele Biotechnology & Pharmaceuticals Inc. SCM Lifescience iPS...
BioCentury | Apr 6, 2019
Finance

Room to rally in 2Q

...Therapeutics Inc. (NASDAQ:ALDX) Helio Vision Inc. 1/29/19 NA $12.5 $12.5 $25.0 Genexine Inc. (KOSDAQ:095700) / SCM Lifescience...
BioCentury | Feb 22, 2019
Company News

SCM, Genexine purchase Argos

...antigens, was in Phase II testing to treat HIV infection. Argos Therapeutics Inc., Durham, N.C. SCM Lifescience...
...Genexine Inc. (KOSDAQ:095700), Seoul, South Korea Business: Cancer, Infectious, Gene/Cell therapy Chris Lieu AGS-004 rocapuldencel-t (AGS-003) Argos Therapeutics Inc. Genexine Inc. SCM Lifescience...
BioCentury | Sep 7, 2018
Financial News

SCM raises $35M series C for stem cells to treat inflammation

SCM Lifescience (Incheon, South Korea) closed a $35 million series C round from 15 investors last Friday to advance its pipeline of disease-specific mesenchymal stem cell therapies. Seoul-based investors DS Asset Management and Neoplux contributed...
BioCentury | Aug 3, 2018
Company News

SCM Lifescience, Yozma in MOU to develop stem cell therapies

...SCM Lifescience, Incheon, South Korea Yozma Bio Science Holdings, Seoul, South Korea Business: Gene/Cell Therapy Elizabeth S. Eaton SCM Lifescience Yozma...
Items per page:
1 - 7 of 7
BioCentury | Jul 2, 2020
Finance

SK becomes Korea’s third-largest public healthcare company after $800M IPO

...SCM Lifescience (KOSDAQ:298060) raised $154.3 million on June 17. Elizabeth S. Eaton, Staff Writer SK Biopharmaceuticals Co. Ltd. Gencurix Inc. SCM Lifescience...
BioCentury | Jun 3, 2020
Finance

Daily Chart: IPO queue grows to 20 life sciences companies

...Therapeutics Inc. Generation Bio Co. Avidity Biosciences LLC Vaxcyte Inc. Royalty Pharma Burning Rock Biotech Arya Sciences Acquisition Corp. SK Biopharmaceuticals Co. Ltd. SCM Lifescience Aptamer...
BioCentury | Apr 19, 2019
Company News

Allele, SCM partner to develop iPS cell therapies for diabetes

...companies will first focus on an autologous therapy for certain forms of Type IIIc diabetes. SCM Lifescience...
...acute pancreatitis, severe atopic dermatitis and liver cirrhosis. Elizabeth S. Eaton, Staff Writer Allele Biotechnology & Pharmaceuticals Inc. SCM Lifescience iPS...
BioCentury | Apr 6, 2019
Finance

Room to rally in 2Q

...Therapeutics Inc. (NASDAQ:ALDX) Helio Vision Inc. 1/29/19 NA $12.5 $12.5 $25.0 Genexine Inc. (KOSDAQ:095700) / SCM Lifescience...
BioCentury | Feb 22, 2019
Company News

SCM, Genexine purchase Argos

...antigens, was in Phase II testing to treat HIV infection. Argos Therapeutics Inc., Durham, N.C. SCM Lifescience...
...Genexine Inc. (KOSDAQ:095700), Seoul, South Korea Business: Cancer, Infectious, Gene/Cell therapy Chris Lieu AGS-004 rocapuldencel-t (AGS-003) Argos Therapeutics Inc. Genexine Inc. SCM Lifescience...
BioCentury | Sep 7, 2018
Financial News

SCM raises $35M series C for stem cells to treat inflammation

SCM Lifescience (Incheon, South Korea) closed a $35 million series C round from 15 investors last Friday to advance its pipeline of disease-specific mesenchymal stem cell therapies. Seoul-based investors DS Asset Management and Neoplux contributed...
BioCentury | Aug 3, 2018
Company News

SCM Lifescience, Yozma in MOU to develop stem cell therapies

...SCM Lifescience, Incheon, South Korea Yozma Bio Science Holdings, Seoul, South Korea Business: Gene/Cell Therapy Elizabeth S. Eaton SCM Lifescience Yozma...
Items per page:
1 - 7 of 7